• News
  • SAN DIEGO
  • Finance

Ligand's 1Q revenues increase 37% from 2013

Ligand Pharmaceuticals Inc. (Nasdaq: LGND) Wednesday reported total revenues for the first quarter of 2014 increased 37 percent to $16 million, compared with the first quarter of 2013.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!